Live
- 5.0-magnitude quake hits Alaska Peninsula
- AP assembly elections: Filing of nominations in full swing in the state
- Alaya F stuns in denim look, exudes boss babe energy
- Brillare Clinic Celebrates First Anniversary with Gratitude and Glamour
- Tillu Square: Sidhu Jonnalagadda’s Film to Stream on Netflix in 5 Languages
- Sharwanand’s ‘Maname’ teaser: A glimpse into a refreshing tale
- Hyderabad: ‘SSMB 29’ pre-production underway; team spotted at airport
- LG raises $800 million bond for R&D & facility investments
- Sandeep Reddy Vanga heaps Praise on ‘Pottel’ Teaser, Compares it to Malayalam Cinema
- Telugu Desam Party Gains Support in Cheepurupalli Constituency as 500 Families Join from YCP"
Telangana Life Sciences Advisory Committee reconstituted
Minister KTR on Wednesday chaired the first meeting of the Life Sciences Advisory Committee
Minister KTR on Wednesday chaired the first meeting of the Life Sciences Advisory Committee, reconstituted with members of industry and academia with a term of two years
Hyderabad: Minister KTR on Wednesday chaired the first meeting of the Life Sciences Advisory Committee, reconstituted with members of industry and academia with a term of two years.
Satish Reddy, chairman, Dr. Reddy's Laboratories will be the chairman, Mahima Datla, MD of Biological E will serve as vice-chairman and Director Life Sciences, Government of Telangana will be convener for the committee.
The objective of the Life Sciences Advisory Committee is to serve a structured interface between the government, industry and academia. The first committee was formed in the year 2016 under the chairmanship of Prof. D. Balasubramian, Director Emeritus (Research), LV Prasad Eye Institute and Satish Reddy as the vice chairman.
The committee supported the planning of Hyderabad Pharma City, organization of BioAsia-State's flagship event and various other initiatives. The reconstituted committee consists of officials from industries department, leaders from industry and research institute covering pharmaceuticals, biotechnology, medical devices, digital health, etc.
